InvestorsHub Logo
Followers 48
Posts 12043
Boards Moderated 0
Alias Born 09/12/2017

Re: None

Friday, 06/14/2019 8:48:27 AM

Friday, June 14, 2019 8:48:27 AM

Post# of 111073
SMSNA Position Statement on Restorative Therapies for ED:

There exists robust basic science evidence in a variety of animal models (aged, diabetic, cavernous nerve injury) supporting the ability of LiSWT and SCT to improve erectile function. However, to date, there is an absence of robust clinical trial data supporting their efficacy and long-term safety in humans.

Hmmm, "an absence of robust clinical trial data supporting their efficacy and long-term safety in humans."

http://www.smsna.org/V1/news/433-smsna-position-statement-on-restorative-therapies-for-ed

http://www.smsna.org/V1/images/SMSNA_Position_Statement_RE_Restorative_Therapies.pdf

Yup, CELZ's year long clinical trial ending in August 2018 and yet there's still an ABSENCE of data supporting its efficacy and long-term safety in humans...hmmmmm, wonder why....epic failure?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News